The 18FDG PET imaging of an olfactory paranoid syndrome (case report);Paranoidní syndrom vlastního zápachu v obraze 18FDG PET (kazuistika)

Psychiatrie

Volumn 7, Issue 3, 2003, Pages 214-217

  Kopeček, Miloslav ^a   Horáček, Jiří ^b   Motlová, Lucie ^b   Preiss, Marek ^b   Bělohlávek, Otakar ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b NONE

Author keywords

Delusion disorder; Glucose metabolism; Olfactory paranoid syndrome of own body smell; Positron emission tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN RADIOGRAPHY; BRAIN REGION; CASE REPORT; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; INSULA; OLFACTORY PARANOID SYNDROME; PARANOID PSYCHOSIS; POSITRON EMISSION TOMOGRAPHY; SYNDROME;

EID: 0141480017     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Blackwood NJ, Howard RJ, Bentall RP, Murray RM. Cognitive neuropsychiatric models of persecutory delusions. Am J Psychiatry 2001;158:527-539.
2. Blackwood NJ, Howard RJ, ffytche DH, Simmons A, Bentall RP, Murray RM. Imaging attentional and attributional bias: an fMRI approach to the paranoid delusion. Psychol Med 2000;30:873-883.
3. Devinsky O, Khan S, Alper K. Olfactory reference syndrome in a patient with partial epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 1998;11:103-105.
4. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 1996;153:41-49.
5. Jibiki I, Kagara Y, Kishizawa S, Kurokawa K, Fukushima T, Furuta H, Yamaguchi N. Case study of monosymptomatic delusion of unpleasant body odor with structural frontal abnormality. Neuropsychobiology 1994;30:7-10.
6. Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899-905.
7. Kwon JS, Kim JJ, Lee DW, Lee JS, Lee DS, Kim MS, Lyoo IK, Cho MJ, Lee MC. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res 2003;122:37-47.
8. Lohmann T, Nishimura K, Sabri O, Klosterkotter J. Successful electroconvulsive therapy of Cotard syndrome with bitemporal hypoperfusion Nervenarzt 1996;67:400-403.
9. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002;159:728-737.
10. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry SuppL 1998;26-37.
11. Stein MB, Leslie WD. A brain single photon-emission computed tomography (SPECT) study of generalized social phobia. Biol Psychiatry 1996;39:825-828.
12. Toone BK. Psychomotor seizures, arterio-venous malformation and the olfactory reference syndrome. A case report. Acta Psychiatr Scand 1978;58:61-66.
13. Vacek J. Paranoidni syndrome vlastního zápachu. Praha: Psychiatrické centrum, 1992;100 s.
14. Wada T, Kawakatsu S, Komatani A, Okuyama N, Otani K. Possible association between delusional disorder, somatic type and reduced regional cerebral blood flow. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:353-357.